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Abstract 
Although aggression is a common symptom of psychiatric disorders the drugs available to treat 
it are non-specific and can have unwanted side effects. In this study we have used a behavioural 
platform in a phenotypic screen to identify drugs that can reduce zebrafish aggression without 
affecting locomotion. In a three tier screen of ninety-four drugs we discovered that caffeine and 
sildenafil can selectively reduce aggression. Caffeine also decreased attention and increased 
impulsivity in the 5-choice serial reaction time task whereas sildenafil showed the opposite 
effect. Imaging studies revealed that both caffeine and sildenafil are active in the zebrafish 
brain, with prominent activation of the thalamus and cerebellum evident. They also inter- 
act with 5-HT neurotransmitter signalling. In summary, we have demonstrated that juvenile 
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zebrafish are a suitable model to screen for novel drugs to reduce aggression, with the po- 
tential to uncover the neural circuits and signalling pathways that mediate such behavioural 
effects. 
© 2019 The Author(s). Published by Elsevier B.V. This is an open access article under the CC 
BY-NC-ND license. ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1. Introduction 
Aggression is an adaptive behaviour that animals use to
protect offspring, defend or obtain resources and establish
social hierarchies ( Nelson and Trainor, 2007 ). However,
heightened aggression can cause injury or death mean-
ing that expression of this behaviour must be tightly
controlled. In humans, aggression can also be a non-
specific symptom of several psychiatric disorders including
attention-deficit/hyperactivity disorder (ADHD), bipolar
disorder, conduct disorder, schizophrenia and substance
abuse disorder ( Nevels et al., 2010 ). 
Human aggression can be managed by a combination
of behavioural, cognitive and pharmacological therapies.
Current drugs used to treat aggression include psychos-
timulants, mood stabilisers, anti-epilepsy drugs, selective
5-HT reuptake inhibitors and agonists of alpha-2 adren-
ergic receptors ( Connors et al., 2006 ; Loy et al., 2012 ;
Nevels et al., 2010 ; Tcheremissine and Lieving, 2006 ).
However, these drugs are not specific and often tar-
get a small number of signalling pathways . Furthermore,
these drugs do not work in all patients and can have
unwanted side-effects making them unsuitable for long-
term use ( Nevels et al., 2010 ; Polzer et al., 2007 ; Scotto
Rosato et al., 2012 ; Wernicke et al., 2003 ). The existence
of two broad subtypes of aggression (impulsive/reactive
and instrumental/proactive) with distinct genetic and neu-
rological bases complicates treatment of this behaviour
( Blair, 2010 ; Kempes et al., 2005 ; Montoya et al., 2012 ;
Nevels et al., 2010 ; Scotto Rosato et al., 2012 ). Each sub-
type is associated with particular psychiatric disorders and
may respond to different drugs ( Pappadopulos et al., 2006 ).
It is clear that there is an unmet clinical need for safer, more
potent drugs to treat aggression ( Nevels et al., 2010 ). 
Traditionally, drug screens have focussed on finding com-
pounds that interact with defined molecular targets. How-
ever, lack of knowledge of the molecular basis of com-
plex behaviours such as aggression limits this approach.
Recent research has shown that behaviour-based screens
can be used to identify novel psychoactive compounds
( MacRae and Peterson, 2015 ; Rihel and Schier, 2012 ). Com-
pared to in vitro screens, whole organism paradigms main-
tain the complex architecture of the brain making them
ideal to examine drugs that act at multiple receptors.
The zebrafish is an excellent vertebrate model for in vivo
drug discovery ( Cunliffe, 2016 ) due to their short gener-
ation time, small size and the possibility to apply com-
pounds by immersion. Numerous robust tests to measure
both larval and adult zebrafish behaviour have already been
established ( Norton, 2013 ). Small molecules that can al-
ter sleep, photomotor response, light/dark behaviour, lo-
comotion, feeding, freezing and susceptibility to seizures
have been identified demonstrating the feasibility of thisPlease cite this article as: H.C. Gutiérrez, I. Vacca and G. Schoenma
identifies caffeine and sildenafil, European Neuropsychopharmacology, approach ( Baxendale et al., 2012 ; Copmans et al., 2016 ;
Fraser et al., 2017 ; Jordi et al., 2018 ; Kokel et al., 2010 ;
Rennekamp et al., 2016 ; Rihel et al., 2010 ; Vliet et al.,
2017 ). 
Previous research in our laboratory and others has used
zebrafish to study the genetic and pharmacological basis
of aggression ( Carreno Gutierrez et al., 2018 ; Jones and
Norton, 2015 ; Norton, 2019 ). Zebrafish display character-
istic agonistic postures that include erection of the fins,
thrashing the tail, biting, splashing and directing short
bouts of swimming against an opponent ( Gerlai et al.,
2000 ; Laan et al., 2018 ). We have identified fibroblast
growth factor receptor 1a as novel aggression-linked gene
( Norton et al., 2011 ) and demonstrated that nitric oxide
and 5-HT interact to control this behaviour ( Carreno Gutier-
rez et al., 2017 ). We have also built a platform to mea-
sure mirror-induced aggression in juvenile zebrafish and
validated software to automatically quantify our data
( Carreno Gutierrez et al., 2018 ). 
In this study we set out to identify novel drugs that can
reduce zebrafish aggression. We selected ninety drugs from
published research and recorded both aggression and loco-
motion. We used a three-tiered strategy that increased in
stringency at each step to identify the most promising can-
didates. We identified caffeine and sildenafil as drugs that
consistently decrease aggression with a lesser effect upon
locomotion. Both drugs reduce aggression at different life
stages but had an opposite effect upon cognitive impulsiv-
ity. By combining whole brain imaging and neurochemistry
we determined the brain areas and neurotransmitter sig-
nalling pathways that mediate activity of these drugs. As
well as determining novel compounds to treat aggression,
this research further demonstrates the utility of zebrafish
for phenotype-based drug screens. 
2. Experimental procedures 
2.1. Zebrafish strains, care and maintenance 
Adult and juvenile zebrafish were maintained at the Universities
of Leicester, Portsmouth and Exeter using standard protocols and
in accordance with institutional guidelines for animal welfare. All
experiments were carried out using AB wild-type zebrafish apart
from the neural imaging (see below). 
2.2. Screen design 
The drug screen was performed as described in Carreno Gutier-
rez et al. (2018 ) and Norton (2019) . Behaviour was measured in
small plastic tanks (9 × 4.2 × 4 cm) with three white opaque
walls and one clear wall. Each tank was filled with 100 ml wa-
ter from the main aquarium facility. Groups of 20 juvenile ze-cker et al., Screening for drugs to reduce zebrafish aggression 
https://doi.org/10.1016/j.euroneuro.2019.10.005 
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b  rafish were habituated to these arenas overnight. Experiments 
ere carried out between 11:00 and 15:00. On the experimental
ay fish were placed into individual tanks using a wide-tipped Pas-
eur pipette. Aggression and locomotion was measured in twelve 
uvenile (one month-old) zebrafish in parallel using a custom-built 
ubicle ( Carreno Gutierrez et al., 2018 ). The ambient light (150
ux) and temperature was controlled. Infrared lighting was pro- 
ided using a light source that formed the floor of the apparatus. 
In the first round of the screen we tested ninety drugs on up to
welve juvenile zebrafish. A description of the drugs used in this
tudy is provided in Supplemental Tables 1 and 3. Drugs were se-
ected by either searching PubMed with the keywords “aggression,
rug, pharmacology (round 1 of the screen), or by using the Chem-
ine website ( http://chemmine.ucr.edu ) as described below. The 
hemical and physical properties of the drugs were identified in the
ubChem database (Supplemental Tables 1 and 3). Drug concentra- 
ions were selected according to previous studies and taking into
ccount the small size of juvenile zebrafish (for references refer
o Supplemental Table 1). Each drug was applied at three differ-
nt concentrations. Fish were immersed in 100 ml of drug solu-
ion for 30 min before being placed into the cubicle and recording
ehaviour. Control fish received a mock treatment (immersion in 
quarium water containing 0.01% DMSO as a vehicle control) and un-
erwent the same handling procedure. The second round of screen-
ng used up to twenty-four juvenile zebrafish. We then chose to fur-
her analyse caffeine and sildenafil in a third round of testing using
round fifty juvenile zebrafish. 
Juvenile aggression was compared with- and without drug treat- 
ent. Behaviour was recoded using video cameras and ViewPoint 
ggression software automatically quantified aggression and loco- 
otion ( Carreno Gutierrez et al., 2018 ). Each experiment lasted
2 min. In the first 2 min juveniles were habituated to the tank fol-
owing transfer. During the next five min locomotion was recorded
ithout visual access to the mirror. Locomotion was quantified by
ideotracking. The divider was then removed and aggressive inter- 
ction with the mirror was recorded for another 5 min. Aggression
as defined as the amount of time a fish spent with its body at an
ngle of 22.5 ° to the mirror and its nose touching the mirror. Ag-
ression was expressed as “aggression units”, an arbitrary unit that
orresponds to the total amount of time spent fighting the mirror
mage ( Carreno Gutierrez et al., 2018 ). Locomotion was expressed
s “locomotion units” based upon the total number of pixels moved
uring an experiment ( Carreno Gutierrez et al., 2018 ). 
.3. Adult behaviour 
dult behavioural experiments were performed using AB wild-type 
ebrafish that were between three and five months old at the start
f testing. Fish were recorded using FlyCapture2 2.5.2.3 software
nd a digital camera from Point Grey Research. The age, sex, and
ize of fish were carefully matched. Caffeine (25, 50, 100 and
00 μM) and sildenafil (1, 5, 10 and 50 μM) were applied by im-
ersion for 30 min. A full description of adult behaviour methods is
ncluded in the Supplemental material. 
.4. High pressure liquid chromatography 
he amine and metabolite content of homogenates of telen- 
ephalon, diencephalon, optic tectum and hindbrain was assessed 
y high performance liquid chromatography (HPLC) with electro- 
hemical detection. Separation was achieved on a 150 × 1.0 mm
18 column (LUNA(2), Phenomenex, UK) and dopamine (DA), 
erotonin (5-HT), 3,4-dihydroxyphenylacetic acid (DOPAC), 
omovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5- 
IAA) were detected electrochemically (750 mV versus an Ag/AgCl Please cite this article as: H.C. Gutiérrez, I. Vacca and G. Schoenma
identifies caffeine and sildenafil, European Neuropsychopharmacology, eference electrode: ANTEC Intro, ANTEC Inc, Netherlands). Peak 
rea for each compound was determined using a PC-based integra-
or (ChromPerfect, Justice Laboratories, USA), and results were 
xpressed as fmol/mg of brain. A full description of HPLC methods
s included in the Supplemental material. 
.5. Data analysis 
tatistical analysis of aggression, locomotion and anxiety like be-
aviour was performed in GraphPad Prism 6 and MATLAB R2018a.
he data set was assessed for normality using a Shapiro–Wilks test.
 student’s t -test or Mann–Whitney U test was then used to com-
are control and drug-treated animals. When comparing more than
wo groups, a one-way ANOVA or Kruskal–Wallis test was used. If
ignificant this was followed up with post hoc Mann–Whitney U -
ests to determine which dosage groups were different from con-
rols. Multiple testing correction for compounds was performed us-
ng false discovery rate (FRD) controlling correction ( Benjamini and
ochberg, 1995 ). Post-hoc tests were not corrected. Data analysis
or the 5-Choice serial reaction time task (5-CSRTT) and fear condi-
ioning was carried out in SPSS. Data pertaining to correct responses
n the 5-CSRTT and premature (impulsive) responses were assessed
sing general linear mixed effects models. In both models, fixed
ffects were ‘dose’, and random effects were ‘subject ID’. This al-
owed us to examine differences for each dose from control, taking
ach fishes’ repeated measures into account while controlling for
on-independence of replicates. Data pertaining to fear condition-
ng were analysed using a 2-way mixed design analysis of variance
ANOVA), with drug treatment (5 levels [0, 50 μM caffeine, 100 μM
affeine, 5 μM sildenafil, 50 μM sildenafil]) as the between subjects
actor and conditioning (2 levels [baseline, post-conditioning]) as 
he within-subjects factor. The dependent variable was preference 
or the conditioned stimulus. High pressure liquid chromatography
ata were subjected to 2-way ANOVA with significant main effects
f drugs interrogated post hoc with Dunnett’s multiple compari-
on test. All data are presented as mean ±SEM. Type-1 error rate
as set at alpha = 0.05 for all analyses. Asterisks in figures indi-
ate significant differences: ( ∗) p < 0.05, ( ∗∗) p < 0.01 and ( ∗∗∗)
 < 0.001. 
. Results 
.1. First round screen of ninety drugs 
ur laboratory has developed a protocol to automatically 
ecord and quantify juvenile zebrafish aggression and loco- 
otion ( Carreno Gutierrez et al., 2018 ). Using this setup we
onducted a biased screen of ninety drugs that affect ag-
ression or aggression-related signalling pathways in other 
pecies (Supplemental Table 3). We immersed one month- 
ld wild-type juvenile zebrafish in three concentrations of 
ach drug and recorded their behaviour thirty minutes later.
e first measured locomotion followed by aggressive in- 
eraction with a mirror ( Carreno Gutierrez et al., 2018 ;
erlai et al., 2000 ). A positive hit was defined as a substance
hat would decrease aggression with little to no effect upon
ocomotion. To maximise the number of compounds tested 
e used between nine and twelve juvenile fish per drug
reatment. Depending on the compounds and doses used we
ound both increases and decreases in aggression compared 
o the control fish (Supplemental Table 1) even though the
 value did not reach significance due to the small num-
er of animals analysed. The thirty compounds that werecker et al., Screening for drugs to reduce zebrafish aggression 
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Fig. 1 Caffeine, sildenafil and paraxanthine decrease juvenile zebrafish aggression. Graphs showing aggression and locomotion 
following application of (a) caffeine (Aggression: Mann–Whitney U = 928.5, p = 0.0025; n = 56 control, n = 50 caffeine. Locomotion: 
Mann–Whitney U = 1205, p = 0.2193), (b) sildenafil (Aggression: Mann–Whitney U = 1081, p = 0.0204; n = 56 control, n = 52 sildenafil. 
Locomotion: Mann–Whitney U = 686, p = 0.0578), (c) paraxanthine (Aggression: ANOVA F (3, 122) = 3.871, p = 0.0110; control vs. 
50 μM: p = 0.6213, control vs. 100 μM: p = 0.0154, control vs. 200 μM: p = 0.0169; n = 36 control, n = 30 paraxanthine. Locomotion: 
ANOVA F (3, 122) = 4.653; control vs. 50 μM: p = 0.0094, control vs. 100 μM: p = 0.0034); n = 36 control, n = 30 paraxanthine. (d) 
Theobromine (Aggression: ANOVA F (3, 116) = 1.284, p = 0.2831; n = 30 control, n = 30 theobromine. Locomotion: ANOVA F (3, 116), 
p = 0.1512); n = 30 control, n = 30 theobromine. (e) Theophylline (Aggression: ANOVA F (3, 118) = 0.0568, p = 0.9821; n = 35 control, 
n = 30 50 μM, n – 28 100 μM, n = 29 200 μM theophylline. Locomotion: ANOVA F (3, 118) = 0.5718, p = 0.6347); n = 35 control, n = 30 
50 μM, n – 28 100 μM, n = 29 200 μM theophylline. (f) Vardenafil (Aggression: ANOVA F (3, 119) = 0.3432, p = 0.7941; n = 35 control, 
n = 30 0.1 μM, n – 28 1 μM, n = 30 10 μM vardenafil. Locomotion: ANOVA F (3, 120) = 1.619, p = 0.1885); n = 35 control, n = 30 
0.1 μM, n – 28 1 μM, n = 30 10 μM vardenafil. One-way ANOVA followed by Dunnett’s post hoc; n = 28–36 each experimental group. 
∗ p < 0.05, ∗∗ p < 0.01. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 most effective at reducing aggression were selected to be
retested. 
3.2. Second round screen of positive hits and 
validation of caffeine and sildenafil activity 
We re-tested these thirty compounds in a second batch of
experiments using up to thirty juvenile zebrafish. Despite
using a larger number of animals we still generated rela-
tively few significant results after correcting for the false
discovery rate due to multiple comparisons (Supplemental
Table 1). In some cases (e.g. tacrine) a reduction of aggres-
sion was also accompanied by a significant decrease in lo-
comotion, making them unsuitable for further analysis. We
therefore chose caffeine and sildenafil for further exami-
nation based upon their ability to reduce aggression, lim-
ited effect upon locomotion and known safety profile in hu-
mans. We tested caffeine and sildenafil rigorously using a
large number of juvenile zebrafish ( Fig. 1 and Supplemental
Table 1). Caffeine deceased aggression at 100 μM withoutPlease cite this article as: H.C. Gutiérrez, I. Vacca and G. Schoenma
identifies caffeine and sildenafil, European Neuropsychopharmacology, affecting locomotion ( Fig. 1 (a)) and sildenafil decreased ag-
gression at 10 μM with only a trend effect upon locomotion
( Fig. 1 (b)). 
3.3. Identification and characterisation of drugs 
structurally related to caffeine and sildenafil 
We next identified chemical compounds that are struc-
turally related to caffeine and sildenafil. We used the Chem-
Mine website to search the Pubchem database for com-
pounds with a similar molecular structure to caffeine and
sildenafil (Supplemental Table 4). We clustered these drugs
using multidimensional scaling and identified the caffeine
derivatives paraxanthine, theobromine and theophylline
and the sildenafil derivative vardenafil (Supplemental Fig.
2 and Supplemental Table 4). Paraxanthine significantly re-
duced juvenile zebrafish aggression at the two highest con-
centrations used (100 μM and 200 μM; Fig. 1 (c)) whereas
the other drugs did not ( Fig. 1 (d)–(f)). This demonstratescker et al., Screening for drugs to reduce zebrafish aggression 
https://doi.org/10.1016/j.euroneuro.2019.10.005 
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o  hat paraxanthine may also represent a suitable compound 
o decrease zebrafish aggression. 
.4. Caffeine and sildenafil alter neural activity 
n the larval zebrafish brain 
affeine and sildenafil can both cross the blood brain barrier
nd act centrally to modify behaviour ( Kouvelas et al., 2009 ;
atson et al., 2002 ). We used transgenic elavl3:GCaMP6s- 
xpressing zebrafish to image activity in response to caf- 
eine or sildenafil in the brain of four day-old larvae
 Winter et al., 2017 ) (Supplemental Fig. 3). Although four
ay-old zebrafish cannot perform complex behaviours such 
s aggression, this approach allowed us to identify a sig- 
ature of neural activity triggered by these drugs. Applica- 
ion of 100 μM caffeine caused a trend to a non-significant
ncrease in sharp pulses of neural activity (peak intensity; 
ig. 2 (a) and Supplemental Table 2) in nearly all brain ar-
as examined. The increase in peak intensity reached sig- 
ificance in the diencephalon and anterior commissure as 
ell as the eminentia granularis and the caudal lobe of the
erebellum (Supplemental Table 2). Area under the curve 
AUC) analysis also revealed a trend decrease of activity 
n the inferior raphe, interpeduncular nucleus and tectum 
tratum periventriculare ( Fig. 2 (b) and film 1,2 (film 1: wa-
er treated; film 2: caffeine treated). Immersion in silde- 
afil led to trend decreases in peak intensity in the olfactory
ulb and eyes, habenulae, eminentia granularis, tangential 
estibular neurons and vagal ganglia ( Fig. 2 (c) and Supple-
ental Table 2). Trend increases in peak intensity were 
een in the anterior commissure, diencephalon, tegmen- 
um, rhombencephalon and noradrenergic neurons of the 
nterfascicular and vagal areas. Application of 10 μM silde- 
afil significantly increased AUC fluorescence in the eminen- 
ia thalami and caused a trend increase in many other dien-
ephalic areas ( Fig. 2 (d), Supplemental Table 2 and film 1,3
film 1: water treated; film 3: sildenafil treated). Together, 
hese results show that different regions of the brain re-
pond to caffeine or sildenafil application. 
.5. Caffeine and sildenafil reduce adult 
ebrafish aggression 
e have previously shown that juvenile and adult ze- 
rafish express similar aggression levels across the lifespan 
 Carreno Gutierrez et al., 2018 ). We assessed the ability
f caffeine and sildenafil to reduce adult zebrafish mirror- 
nduced aggression. Both caffeine ( Fig. 3 (a)) and sildenafil 
educed ( Fig. 3 (d)) adult aggression and had a less pro-
ounced effect on locomotion ( Fig. 3 (c) and (f)) in agree-
ent with our juvenile zebrafish data. The time spent in 
he mirror zone was only altered by the highest concentra-
ion of caffeine ( Fig. 3 (b)) suggesting that the reduction of
ggression was selective. We also measured anxiety-like be- 
aviour in the novel tank test (NTT). Immersion in caffeine
r sildenafil did not alter the time spent in the top ( Fig. 3 (g)
nd (k)) of the novel tank, the time spent freezing, angu-
ar velocity ( Fig. 3 (i) and (m)) or total distance swum (apart
rom 100 μM caffeine; Fig. 3 (j) and (n)). This suggests thatPlease cite this article as: H.C. Gutiérrez, I. Vacca and G. Schoenma
identifies caffeine and sildenafil, European Neuropsychopharmacology, either caffeine nor sildenafil are anxiogenic at the concen-
rations that we tested. 
.6. Caffeine and sildenafil alter attention and 
mpulsivity but not learning 
n mammals, aggression can be divided into impul- 
ive/reactive and instrumental/proactive subtypes 
 Blair, 2010 ). We investigated whether caffeine and
ildenafil might modify zebrafish aggression by altering 
heir levels of attention, impulsivity or learning (Supple- 
ental Fig. 1). We trained ten adult wild-type zebrafish to
ssociate a light with a food reward in the 5-choice serial
eaction time task (5-CSRTT). We then introduced a 10 s
ariable pre-stimulus interval and tested fish for seven 
ays. Fish were treated with either sildenafil (5 μM/50 μM),
affeine (50 μM/100 μM) or no drug (alternating between
rug and no-drug) each day. Caffeine decreased the number
f correct responses in the 5-CSRTT and increased prema-
ure (impulsive) responses ( Fig. 4 (a) and (b)). Conversely,
ildenafil showed an opposite phenotype, with an increase 
n the number of correct responses and a decrease in pre-
ature (impulsive) responses that did not reach significance 
 Fig. 4 (c) and (d)). We examined whether acute exposure
o caffeine or sildenafil affected learning by measuring 
hange in preference for a conditioned stimulus following 
airing with a brief, mild electric shock. Neither caffeine
or sildenafil altered behaviour in this test compared to
ontrol zebrafish, suggesting that aversive learning is not 
ffected by these drugs ( Fig. 4 (e)). 
.7. Acute caffeine and sildenafil application 
eightens 5-HT levels in the brain 
he behavioural profile of caffeine and sildenafil prompted 
s to investigate the neurotransmitter signalling pathways 
hat they modulate. We immersed adult wild-type zebrafish 
n 100 μM caffeine or 10 μM sildenafil and used HPLC to
easure the basal levels of 5-HT, DA and their metabolites.
pplication of either drug increased the concentration of 5-
T in the telencephalon, diencephalon, optic tectum and 
hombencephalon, and 5-HIAA in the telencephalon, dien- 
ephalon and optic tectum compared to control treated 
ebrafish ( Fig. 5 (a)–(d)). The levels of dopamine, DOPAC
nd HVA were unaffected by drug application. Caffeine ap-
lication decreased the utilisation ratio of 5-HIAA/5-HT in 
he diencephalon and rhombencephalon ( Fig. 5 (f) and (h)),
hereas sildenafil decreased the utilisation ratio of both 5-
IAA/5-HT and HVA/DA in the rhombencephalon ( Fig. 5 (h)).
his demonstrates that both caffeine and sildenafil act cen-
rally to modify monoaminergic neurotransmission. 
. Discussion 
n this study we have used a biased screen to identify drugs
hat reduce zebrafish aggression but not locomotion. We ap-
lied three concentrations of each drug to maximise the
umber of positive hits identified. Our screen had a hit rate
f 3.1% (two out of 94 drugs) that is similar to other screenscker et al., Screening for drugs to reduce zebrafish aggression 
https://doi.org/10.1016/j.euroneuro.2019.10.005 
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Fig. 2 Neural activity following drug application. (a) Radar plot showing 100 μM caffeine peak intensity. (b) Radar plot showing 
100 μM caffeine area under curve. (c) Radar plot showing 10 μM sildenafil peak intensity. (d) Radar plot showing 10 μM sildenafil area 
under curve. Orange lines in a–d show response to drug and blue lines show control response to water. Legend: 1. Eyes; 2. Olfactory 
bulb; 3. Olfactory epithelium; 4. Telencephalon; 5. Anterior commissure; 6. Pallium; 7. Subpallium; 8. Diencephalon; 9. Dorsal 
thalamus; 10. Eminentia thalami; 11. Habenulae; 12. Intermediate hypothalamus; 13. Pineal; 14. Posterior tuberculum; 15. Preoptic 
area; 16. Pretectum; 17. Rostral hypothalamus; 18. Ventral thalamus; 19. Mesencephalon; 20. Tectum stratum periventriculare; 21. 
Tectum neuropil; 22. Tegmentum; 23. Torus longitudinalis; 24. Torus semicircularis; 25. Rhombencephalon; 26. Area postrema; 27. 
Cerebellum; 28. Corpus cerebelli; 29. Eminentia granularis; 30. Inferior olive; 31. Interpeduncular nucleus; 32. Lateral reticular 
nucleus; 33. Lobus caudalis cerebelli; 34. Locus coeruleus; 35. Mauthner neuron; 36. Medial vestibular nucleus; 37. Noradrenergic 
neurons; 38. Inferior raphe; 39. Superior raphe; 40. Tangential vestibular nucleus; 41. Valvula cerebelli; 42. Vagal ganglia; 43. Spinal 
cord; 44. Neuropil region. (e) Control maximum projection of neural activity. (f) 100 μM caffeine maximum projection of neural 
activity. g) 10 μM sildenafil maximum projection of neural activity. n = 8 control, n = 8 100 μM caffeine and n = 8 10 μM sildenafil. 
(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
 
 
 
 
 
 
 
 
 
 
 
 
 for drugs that alter sleep (8.2%) ( Rihel and Schier, 2012 ) and
seizure liability (2.3%) ( Baxendale et al., 2012 ) in zebrafish.
Caffeine and sildenafil significantly reduced both juvenile
and adult aggression with a smaller effect on locomotion
( Figs. 1 and 3 ). These drugs also had opposite effects upon
attention and impulsivity ( Fig. 4 (a)–(d)) but did not alter
anxiety-like behaviour ( Fig. 3 (g)–(n)) or learning ( Fig. 4 (e)).Please cite this article as: H.C. Gutiérrez, I. Vacca and G. Schoenma
identifies caffeine and sildenafil, European Neuropsychopharmacology, A small-scale screen of drugs with a similar molecular struc-
ture as caffeine and sildenafil demonstrated that paraxan-
thine can also reduce aggression ( Fig. 1 (c)). Although we
have not characterised paraxanthine in detail, this approach
shows the feasibility of using zebrafish to screen for deriva-
tives of drugs with potentially more favourable toxicological
and behavioural profiles. cker et al., Screening for drugs to reduce zebrafish aggression 
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Fig. 3 Effect of caffeine and sildenafil on adult zebrafish behaviour. (a–c) Mirror-induced aggression upon caffeine treatment. 
(a) Time spent fighting the mirror in the aggression test (ANOVA: F = 5.809, p = 0.0007; control vs. 25 μM: p = 0.0445, control 
vs. 50 μM: p = 0.0034, control vs. 100 μM: p = 0.0008, control vs. 200 μM: p = 0.0009; n = 9–11 each). (b) Time spent near the 
mirror (ANOVA: F (4, 47) = 1.68, p = 0.1708); n = 9–11 each. (c) Total distance swum (ANOVA: F (4, 47) = 4.568, p = 0.0034; control 
vs. 25 μM: p = 0.0383, control vs. 50 μM: p = 0.0101, control vs. 100 μM: p = 0.0726, control vs. 200 μM: p = 0.9998); n = 9–11 
each. (d–g) Novel tank diving upon caffeine treatment. (d) Time spent at the top (Kruskal–Wallis H (2) = 1.315, p = 0.5182; n = 13–14 
each). (e) Time spent freezing (ANOVA: F (2, 38) = 2.437, p = 0.1010); n = 13–14 each. (f) Angular velocity (ANOVA: F (2, 38) = 2.175, 
p = 0.1275); n = 13–14 each. (g) Total distance swum (Kruskal–Wallis H (2) = 6.038, p = 0.0488; control vs. 50 μM: p > 0.999, control 
vs. 100 μM: p = 0.0408); n = 13–14 each. (h–j) Mirror-induced aggression upon sildenafil treatment. (h) Time spent fighting the mirror 
in the aggression test (Kruskal–Wallis: H (4) = 13.27, p = 0.0100; control vs. 1 μM: p = 0.0046, control vs. 5 μM: p = 0.0366, control 
vs. 10 μM: p = 0.0274, control vs. 50 μM: p = 0.5010; n = 10–12 each). (i) Time spent near the mirror (ANOVA: F (4, 48) = 1.865, 
p = 0.1319); n = 10–12 each. (j) Total distance swum (ANOVA: F (4, 48) = 1.664, p = 0.1739); n = 10–12 each. (K–N) Novel tank diving 
upon sildenafil treatment. (k) Time spent at the top (Kruskal–Wallis: H (2) = 0.0179, p = 0.9910); n = 10–12 each. (l) Time spent 
freezing (Kruskal–Wallis: H (2) = 1.381, p = 0.5014); n = 10–12 each. (m) Angular velocity (Kruskal–Wallis: H (2) = 1.776, p = 0.4114); 
n = 10–12 each. (n) Total distance swum (ANOVA: F (2, 33) = 0.0565, p = 0.9451); n = 10–12 each. One-way ANOVA followed by 
Dunnett’s post hoc or Kruskal Wallis test followed by Dunn’s post hoc. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. 
Please cite this article as: H.C. Gutiérrez, I. Vacca and G. Schoenmacker et al., Screening for drugs to reduce zebrafish aggression 
identifies caffeine and sildenafil, European Neuropsychopharmacology, https://doi.org/10.1016/j.euroneuro.2019.10.005 
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Fig. 4 5-choice serial reaction time task and fear conditioning following caffeine or sildenafil application. a-d) 5-choice serial 
reaction time task. (a) 50 μM caffeine decreases correct responses in the 5-CSRTT. (b) 50 μM and 100 μM caffeine increases 
premature responses in the 5-CSRTT. (c) 5 μM sildenafil increases correct responses in the 5-CSRTT. (d) 5 μM and 50 μM sildenafil 
does not affect premature responses in the 5-CSRTT. (e) Aversive fear conditioning. Correct responses in this test were significantly 
affected by drug dose (linear mixed effects model, fixed effect = dose, random effect = ID nested in test-day; F (4, 65) = 3.28, 
p = 0.02). There was a significant reduction in correct responses from control following exposure to 50 μM ( p = 0.05) but not 100 μM 
caffeine ( p = 0.15; pairwise comparisons). Conversely, application of 50 μM sildenafil significantly increased correct responses 
( p = 0.05), but 5 μM sildenafil did not ( p = 0.44; pairwise comparisons). Regarding premature responses, drug dose had a significant 
main effect (linear mixed effects model, fixed effect = dose, random effect = ID nested in test-day; F (4, 65) = 2.48, p = 0.05). 
Exposure to 50 μM ( p = 0.02) or 100 μM ( p = 0.03) caffeine caused a significant increase in premature responses compared to control 
(pairwise comparisons). There were no significant effects of sildenafil on premature responses ( p > 0.8). Aversive conditioning, 
revealed a significant reduction in preference for the shock-paired stimulus (2-way mixed-design analysis of variance (ANOVA), F (1, 
43) = 65.76, p < 0.001), but there was no main effect of dose ( F (4, 43) = 1.97, P = 0.12), and no dose × conditioning interaction 
( F (4, 43) = 0.27, p = 0.9). This suggests that impaired learning cannot explain our findings in the 5-CSRTT. n = 12 control, n = 12 
100 μM caffeine and n = 12 10 μM sildenafil. 
 
 
 
 
 
 
 
 
 
 
 
 4.1. Caffeine 
Acute immersion in caffeine caused a decrease in the mean
level of both juvenile ( Fig. 1 ) and adult zebrafish aggres-
sion ( Fig. 3 ). Low doses of caffeine can also reduce ago-
nistic behaviour in humans and rats ( Cherek et al., 1984 ;
Wilson et al., 2000 ) indicating that the action of this drugPlease cite this article as: H.C. Gutiérrez, I. Vacca and G. Schoenma
identifies caffeine and sildenafil, European Neuropsychopharmacology, may be conserved across species. Treatment of zebrafish
with caffeine also decreased the number of correct re-
sponses and increased impulsivity ( Fig. 4 (a) and (b)) in the
5-choice serial reaction time task (5-CSRTT). Locomotion
( Fig. 1 (a)), anxiety-like behaviour ( Fig. 3 (g)–(j)) and fear-
conditioning ( Fig. 5 (e)) were unaffected at most of the con-
centrations that we tested. This suggests that the decreasecker et al., Screening for drugs to reduce zebrafish aggression 
https://doi.org/10.1016/j.euroneuro.2019.10.005 
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Fig. 5 Neurochemistry following caffeine or sildenafil application. (a–d) Basal level of monoamines. 5-HT levels are increased by 
caffeine or sildenafil application in the (a) telencephalon, (b) diencephalon, (c) optic tectum and (d) hindbrain. 5HIAA levels are 
increased by caffeine in the (a) telencephalon and (c) optic tectum. (e–h) Utilisation ratio of monoamines. (h) The utilisation ratio 
of dopamine to HVA is decreased by sildenafil in the hindbrain. The utilisation ratio of 5-HT to 5HIAA is decreased by (f) caffeine in 
the diencephalon and (h) both caffeine and sildenafil in the hindbrain. ∗ p < 0.05; ∗∗ p < 0.01, ∗∗∗ p < 0.001: significant difference 
from control (Dunnett’s multiple comparison test, based on significant main effects of drug in two-way ANOVA in telencephalon 
( F (2, 99) = 8.48, p < 0.001), optic tectum ( F (2, 99) = 9.90, p < 0.001) and diencephalon ( F (2, 99) = 3.81, p = 0.026). There was 
no significant main effect of drug in hindbrain ( F (2, 99) = 1.10, p = 0.338); n = 8 control, n = 8 100 μM caffeine and n = 8 10 μM 
sildenafil. 
i  
a
o  
w  
1  
m
c  n aggression relative to control treatment could be due to
 reduction in attention towards the mirror stimulus. 
At dietary levels caffeine acts as a competitive antag- 
nist of adenosine A1 and A2A receptors (A1R and A2AR)Please cite this article as: H.C. Gutiérrez, I. Vacca and G. Schoenma
identifies caffeine and sildenafil, European Neuropsychopharmacology, ith a similar affinity for both targets ( Fredholm et al.,
999 ). At nonpharmacological doses caffeine can also inhibit
onoamine oxidase and phosphodiesterases and mobilise 
alcium stores ( Cappelletti et al., 2015 ; Fredholm et al.,cker et al., Screening for drugs to reduce zebrafish aggression 
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 1999 ; Petzer et al., 2013 ). However, since A2AR knock-out
mice are more aggressive than WT ( Ledent et al., 1997 ) it
seems likely that adenosine signalling might underpin the
decrease in aggression that we observed. 
The behavioural effect of caffeine appears to be concen-
tration dependent ( El Yacoubi et al., 2000 ; Wilson et al.,
2000 ). Previous studies have shown that low doses of caf-
feine (between 1 μM and 5 μM) do not alter adult zebrafish
locomotion whereas high doses (100 μM to 1280 μM) de-
crease locomotion ( Ladu et al., 2015 ; Tran et al., 2017 )
and increase anxiety-like behaviour (520 μM, Egan et al.,
2009 ; Wong et al., 2010 ). In our setup we only observed
decreased locomotion when we applied 200 μM caffeine.
The inconsistency of results across studies could be due to
the genetic background used. Caffeine has a different be-
havioural effect in short-fin wild-type and leopard zebrafish
( Rosa et al., 2018 ); and genetic polymorphisms in the
ADENOSINE A2A RECEPTOR can predict the anxiogenic
profile of caffeine in humans. Alternatively, the dose-
dependent modulation of aggression might be explained by
the activation of different targets at higher concentrations.
Caffeine readily passes the blood-brain barrier and has
both central and peripheral effects ( Watson et al., 2002 ).
Acute application of 100 μM caffeine caused widespread
activation of a large number of larval brain areas that did
not reach significance compared to control-treated animals.
This finding agrees with a study of humans in which a mod-
erate dose of caffeine increases resting brain entropy across
the brain ( Chang et al., 2018 ). Caffeine’s ability to alter be-
haviour might be due to dynamic small-scale changes in the
activity of multiple brain areas rather than a significant al-
teration in one nucleus. Live-imaging identified a significant
increase in peak intensity in the anterior commissure, dien-
cephalon, caudal lobe of the cerebellum and the eminen-
tia granularis ( Fig 2 (f)). Long-term caffeine treatment has
been shown to increase the number of adenosine receptors
in the brainstem and cerebellum of mice ( Marangos et al.,
1984 ). Together, these observations suggest that the cere-
bellum may mediate caffeine’s effect, perhaps via recip-
rocal connections with the telencephalon ( Matsui et al.,
2014 ). In adult zebrafish, immersion in 100 mg/L (520 μM)
caffeine activates neurons in the central part of the dorsal
telencephalon, optic tectum and lateral longitudinal fasci-
cle ( Chatterjee et al., 2015 ). However, our data showed that
at 4 days, 10 μM caffeine did not significantly activate these
brain areas suggesting that there are stage- or concentra-
tion differences in the way in which the zebrafish brain re-
sponds to this drug. 
4.2. Paraxanthine 
Caffeine is metabolised to paraxanthine, theobromine and
theophylline by the enzyme Cytochrome P450A1 ( Ferré
et al., 2013 ). In humans, around 80% of caffeine is
metabolised to paraxanthine although this rate differs in
other species ( Benowitz et al., 1995 ). Paraxanthine blocks
A1R and A2AR with a higher potency than caffeine and
also inhibits Phosphodiesterase 9 (Pde9) ( Orru et al., 2013 ).
Since the majority of caffeine is metabolised to paraxan-
thine it is possible that this compound is responsible for
the pharmacological activity of caffeine ( Benowitz et al.,Please cite this article as: H.C. Gutiérrez, I. Vacca and G. Schoenma
identifies caffeine and sildenafil, European Neuropsychopharmacology, 1995 ). However, the acute exposure time used here argues
against this idea. Alternatively, both drugs could have a
similar effect on A1R and A2AR. Theobromine and theo-
phylline did not reduce aggression in our screen ( Fig. 1 (d)
and (e)) even though they are also non-selective adeno-
sine receptor- and phosphodiesterase inhibitors ( Boswell-
Smith et al., 2006 ; Martínez-Pinilla et al., 2015 ). One ex-
planation for this discrepancy could be that theobromine
and theophylline are more active at cAMP-specific phos-
phodiesterases than paraxanthine which binds to the cGMP-
specific Pde9 ( Essayan, 2001 ; Orru et al., 2013 ). Although
paraxanthine reduced aggression it also significantly re-
duced locomotion when applied at 50 μM and 100 μM con-
centration. This means that paraxanthine does not fulfil the
selection criteria used in our screen design (reduced aggres-
sion in the absence of changes to locomotion), making it a
less interesting compound for future study. 
4.3. Sildenafil 
Sildenafil treatment decreased both juvenile and adult ze-
brafish aggression ( Figs. 1 (b) and 3 (d)). Conversely, the
structurally-related drug vardenafil did not alter aggression
or locomotion ( Fig. 1 (f)). Both sildenafil and vardenafil are
potent phosphodiesterase 5 (PDE5) inhibitors that can pro-
long nitric oxide (NO) signalling ( Essayan, 2001 ). Vardenafil
binds PDE5 ten to forty fold more tightly than sildenafil
making it much more potent and selective ( Bischoff, 2004 ;
Rotella, 2002 ). This difference in potency might explain the
inability of vardenafil to reduce aggression if the concen-
tration that we tested in this study was too high. Silde-
nafil has already been linked to the control of aggression.
Withdrawal of the drug decreased attack latency and in-
creased the frequency and duration of aggression in mice
( Hotchkiss et al., 2005 ). In a separate study, sildenafil was
shown to increase aggression, sexual behaviour, exploration
and anxiety in subordinate mice without changing the social
hierarchy. This suggests that the motivation to be aggressive
had been altered ( Dadomo et al., 2013 , 2011 ). 
Sildenafil also increased the number of correct responses
and decreased impulsivity in the 5-CSRTT ( Fig. 4 (c) and (d))
whereas learning was not affected ( Fig. 4 (e)). This supports
previous work demonstrating the cognitive enhancing effect
of PDE inhibition in macaques ( Rutten et al., 2008 ). Inter-
estingly, sildenafil has a different effect in macaques de-
pending upon the difficulty of the task. While the PDE4 and
PDE5 inhibitors increased performance on the more complex
version of an object-retrieval protocol, no effects were ob-
served on the simpler iterations. This strongly supports our
data, whereby performance on the cognitively demanding
5-CSRTT was improved by sildenafil. 
As well as relaxing peripheral blood vessels, sildenafil can
cross the blood brain barrier and act centrally to enhance
nitric oxide (NO) signalling ( Kouvelas et al., 2009 ). In rat,
mice and human brains Pde5 is restricted to the hippocam-
pus and Purkinje cells of the cerebellum ( Giordano et al.,
2001 ; Kotera et al., 2000 ; Lakics et al., 2010 ; Teich et al.,
2016 ). Imaging of the larval zebrafish brain showed that
acute application of 10 μM sildenafil causes a broad increase
in AUC fluorescence in the diencephalon and decreases
in several forebrain and hindbrain regions. Importantlycker et al., Screening for drugs to reduce zebrafish aggression 
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B  he increase in AUC fluorescence reached significance in 
he eminentia thalami, an ambiguous structure located 
bove the preoptic area and ventral to the prethalamus 
 Mueller, 2012 ). The eminentia thalami disappears during 
ammalian development, whereas it is maintained as the 
entral entopeduncular nucleus (vENT) in adult fish and 
mphibians ( Mueller, 2012 ; Mueller and Guo, 2009 ). The
NSM sends efferent projections to the habenula, optic tec- 
um and pallial forebrain. Afferent projections have been 
apped from the cerebellar Purkinje cells to the thalamus 
 Matsui et al., 2014 ). Although the function of the emi-
entia thalami/vENT is not known, the connection between 
he cerebellum and eminentia thalami could form part of a 
erebellar-thalamus-forebrain loop that controls emotional 
ehaviour (e.g. Tsai et al., 2012 ). Further research, such as
irect manipulation of the eminentia thalami using optoge- 
etic tools, would be required to test this hypothesis. 
.4. Convergence of signalling pathways 
ctivated by caffeine and sildenafil 
lthough both caffeine and sildenafil reduced both juvenile 
nd adult aggression, they had an opposite effect on impul-
ivity ( Fig. 4 (a) and (c)) and produced a different neural sig-
ature in the 4 day-old brain. This makes it difficult to know
hether they decrease aggression via the same neural net- 
ork or signalling pathway. A global reduction of 5-HT activ-
ty has been linked to control of aggression across species; 
nd both caffeine and sildenafil increased the basal level of
-HT throughout the adult brain ( Fig. 5 ), as well as decreas-
ng its utilisation ratio in the diencephalon. However, the 
echanism by which these drugs can alter monoamine sig- 
alling is not yet clear. At high concentrations caffeine can 
nhibit monoamine oxidase ( Fredholm et al., 1999 ) providing
ne possible explanation for the heightened levels of 5-HT 
bserved in this study. Further research, such as measuring 
AO activity using an enzymatic assay after caffeine appli- 
ation ( Carreno Gutierrez et al., 2017 ) would be required to
ddress this issue. Another potentially important signalling 
athway is nitric oxide. Inhibition of Pde5 by sildenafil sta- 
ilises cGMP levels to enhance NO signalling; and adenosine 
ignalling (a target of caffeine) can activate both Nos1 and 
os3 via the adenosine receptor 2b ( Wen and Xia, 2012 ).
owever, caffeine and sildenafil activate different areas of 
he brain, with sildenafil having a broader profile than caf-
eine. Even though both drugs reduce aggression the neural 
ubstrate underlying this behaviour appears to be different. 
uture studies are required to investigate whether caffeine 
nd sildenafil modify aggression via NO or 5-HT signalling. 
In summary, we have used a biased approach to search 
or novel drugs that can reduce zebrafish aggression. We 
emonstrated that both caffeine and sildenafil can decrease 
ggression across the lifespan, although they have the oppo- 
ite effect upon impulsivity. By combining a range of tech-
iques we have identified some of the brain areas and neu-
otransmitter systems that may alter aggression. A major 
rawback of this approach is that because of technical limi-
ations we compared neural activity at larval stages to neu-
ochemistry in the adult brain and behaviour across the 
ifespan. Future work would benefit from identifying the 
ature neural circuits activated by these drugs. The next Please cite this article as: H.C. Gutiérrez, I. Vacca and G. Schoenma
identifies caffeine and sildenafil, European Neuropsychopharmacology, tep for this research would be to further test these com-
ounds in rodent models to investigate whether caffeine 
nd sildenafil reduce aggression across vertebrate species 
 Norton, 2019 ). 
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